当前位置:首页 - 行情中心 - 益佰制药(600594) - 财务分析

益佰制药

(600594)

  

流通市值:31.76亿  总市值:31.76亿
流通股本:7.92亿   总股本:7.92亿

益佰制药(600594)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2024年第一季度实现净利润-0.71亿元,每股收益-0.09元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2024年第一季度最新股东权益312998.28万元,未分配利润123606.75万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2024年第一季度最新总资产470579.84万元,负债157581.56万元。

利润表
报告期2024-03-312023-12-312023-09-302023-06-30
营业总收入572,646,100.112,820,561,0152,136,834,252.041,479,701,367.04
营业总成本635,203,702.042,621,425,841.61,930,208,223.551,316,998,284.2
营业利润-67,731,162.14137,357,956.51199,307,914.36155,743,625.23
利润总额-69,765,713.72132,320,704.64194,907,546.17153,642,341
净利润-71,411,782.7891,357,121.13161,499,907.31121,728,393.61
其他综合收益39,540.83-343,624.32-343,624.32-
综合收益总额-71,372,241.9591,013,496.81161,156,282.99121,728,393.61
资产负债表
报告期2024-03-312023-12-312023-09-302023-06-30
流动资产合计2,035,731,291.562,069,148,018.192,137,225,252.452,204,637,869.4
非流动资产合计2,670,067,070.332,711,205,898.682,764,158,830.052,795,239,628.69
资产总计4,705,798,361.894,780,353,916.874,901,384,082.54,999,877,498.09
流动负债合计1,073,036,097.08929,589,640.18923,181,162.891,164,200,482.25
非流动负债合计502,779,494.19649,409,264.12626,705,120.86523,607,106.47
负债合计1,575,815,591.271,578,998,904.31,549,886,283.751,687,807,588.72
归属于母公司股东权益合计2,999,129,270.683,067,544,538.33,214,168,065.933,172,547,778.33
股东权益合计3,129,982,770.623,201,355,012.573,351,497,798.753,312,069,909.37
负债和股东权益合计4,705,798,361.894,780,353,916.874,901,384,082.54,999,877,498.09
现金流量表
报告期2024-03-312023-12-312023-09-302023-06-30
经营活动现金流入小计769,767,157.873,160,484,140.262,345,919,082.161,579,588,756.66
经营活动现金流出小计674,012,608.92,782,874,327.72,002,763,789.311,377,285,736.07
经营活动产生的现金流量净额95,754,548.97377,609,812.56343,155,292.85202,303,020.59
投资活动现金流入小计11,508,509.9364,788,124.4650,480,020.4676,739.25
投资活动现金流出小计22,157,326.31180,382,397.82152,919,375.55123,494,460.67
投资活动产生的现金流量净额-10,648,816.38-115,594,273.36-102,439,355.09-123,417,721.42
筹资活动现金流入小计148,000,000741,328,819.18540,000,000228,000,000
筹资活动现金流出小计161,974,530.49893,019,030.8684,138,265.86220,627,377.26
筹资活动产生的现金流量净额-13,974,530.49-151,690,211.62-144,138,265.867,372,622.74
汇率变动对现金及现金等价物的影响----
现金及现金等价物净增加额71,131,202.1110,325,327.5896,577,671.986,257,921.91
期末现金及现金等价物余额766,811,919.96695,680,717.86683,933,062.18671,613,312.19
TOP↑